Dawn2d
BLA brainwashes, incites people to terrorism: ex-member
In 2024, the banned BLA emerged as a key perpetrator of terrorist violence in Pakistan. According to the Pakistan Security ...
AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa for an ultra-rare autoimmune disease
Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic ...
Samaa2d
Baloch militant groups BLA, BLF face public outcry over civilian attacks in Pakistan
Recent attacks by BLA and BLF in Balochistan claim civilian lives. Details on incidents, victim accounts, and security ...
Radio Pakistan2d
Int’l Organization reveals banned BLA's exploitation of women
A report by international organization Wilson Center has made startling revelations about the BLA exploiting women for ...
Hosted on MSN1d
BLA uses women to carry out terror acts, claims US think-tank
Washington based renowned think-tank Wilson Centre has made a startling disclosure about the banned Baloch Liberation Army (BLA) exploiting women for carrying out terrorist activities in ...
Hosted on MSN4d
REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA
Replimune Group, Inc. REPL announced that the FDA has accepted the biologics license application (BLA) for its lead pipeline ...
Dunya News2d
Former BLA commander renounces violence, exposes foreign support for Baloch insurgency
QUETTA (Dunya News) – Former Baloch Liberation Army (BLA) commander Najibullah, along with other militants, denounced ...
Cure Today3d
The FDA Accepts a BLA for RP1 Plus Opdivo in Advanced Melanoma
The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have ...
Dawn2d
Former ‘BLA commander’ lifts veil from ‘separatist struggle’
QUETTA: A former ‘commander’ of the banned Baloch Liberation Army on Friday disclosed how it and other such outfits had been carrying out an armed separatist campaign.
MeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder Value
MeiraGTx's financials show $125 million in cash, but additional funding will be needed within the next 12 months. Click for ...
Replimune's BLA For RP1-Nivolumab Combo Gets FDA Approval For Advanced Melanoma, Stock Surges
(RTTNews) - Replimune Group, Inc. (REPL), Tuesday announced that the U.S. Food and Drug Administration has accepted the Biologics License Application for RP1 in combination with Nivolumab for the ...